˘ ˇ ˆ ˆ ˙ ˝ ˛ˇ ˚ ˆˆ ˘˜ ˚ ˜ !˙ #$% ˆ - WHO
2 1. Introduction BCG vaccine is the only vaccine currently available for immunization against tuberculosis (TB) infections and has been used since the 1920s.
Download ˘ ˇ ˆ ˆ ˙ ˝ ˛ˇ ˚ ˆˆ ˘˜ ˚ ˜ !˙ #$% ˆ - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Revised National Tuberculosis Control Programme …
health.bih.nic.in1 INTRODUCTION The emergence of resistance to drugs used to treat tuberculosis (TB), and particularly multidrug-resistant TB (MDR-TB), has become a significant public health problem in a number of countries and an obstacle to
26. HIV-1 associated Encephalopathy and Myelopathy
www.hivmedicine.comHIV encephalopathy 647 26. HIV-1 associated Encephalopathy and Myelopathy Christian Eggers and Thorsten Rosenkranz HIV encephalopathy The primary cause of HIV encephalopathy (HIVE) is the infection of the CNS
What you need to know about vaccinations
www.kznhealth.gov.zaABOUT VACCINATIONS Asaparent,youwillwanttoknowwhyvaccinatingyourchildis important. Inthepast,diseasessuchassmallpoxandpoliostruckfearintothe heartsofparents ...
Guidelines for Assuring Quality - The Australian …
www.theasm.org.auGuidelines for Assuring Quality of Medical Microbiological Culture Media July 2012
DIAGNOSTIC APPROACH TO MYELOPATHIES - CIR
www.webcir.orgreview articles Rev Colomb Radiol. 2011; 22:(3):1-21 1 DIAGNOSTIC APPROACH TO MYELOPATHIES ENfOquE DIAGNóSTICO DE LAS MIELOPATíAS Ana María Granados Sánchez1 Lina María García Posada2 César Andrés Ortega Toscano2 Alejandra López López2 SUMMARY
THE NATIONAL TUBERCULOSIS AND LEPROSY …
www.who.int2 FOREWORD The publication of the third edition of the National Tuberculosis and Leprosy Programme NTLP) manual marks a big step forward because it underscores the Programme’s commitment to providing the latest knowledge and
GUIDE TO INFECTION PREVENTION FOR …
www.cdc.gov3 Version 2.3- September 2016 INTRODUCTION The transition of healthcare delivery from acute care hospitals to outpatient (ambulatory …
Treatment of mycobacterial infections - Home: OIE
www.oie.intRev. sci. tech. Off. int. Epiz., 20 (1) 57 Dormancy (latency) As mentioned in the Introduction, the ability of mycobacteria to persist in a dormant state is also an important consideration
Related search queries
Revised National Tuberculosis Control Programme, Introduction, 1 associated Encephalopathy and Myelopathy, Need to know about vaccinations, Guidelines for Assuring Quality, DIAGNOSTIC APPROACH TO MYELOPATHIES, THE NATIONAL TUBERCULOSIS AND LEPROSY, The National Tuberculosis and Leprosy Programme, GUIDE TO INFECTION PREVENTION, Treatment of mycobacterial infections, Mycobacteria